Language: Spanish
References: 10
Page: 10-12
PDF size: 47.83 Kb.

Text Extraction

No abstract

REFERENCES

1. Fletcher CM. Definition, classification and etiology of chronic bronchitis. Poumon Coeur 1965; 21: 1239-1248.

2. Pauwels RA, Buist S, Calvery PMA, Jenkins C, Hurd S. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Am J Respir Crit Care Med 2001; 163: 1256-1276.

3. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, Wood KL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006; 130: 200-206.

4. Global Strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Document 2006. NHLBI/WHO Global Initiative for chronic obstructive lung disease. www.goldcopd.org

5. Celli BR, MacNee W, and Committee Members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.

6. Agusti AGM. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 367-370.

7. Sansores RH, Ramirez–Venegas A. Guías para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Rev Inst Nal Enf Resp y Neuma Cir Tórax 2003; 292: 50.

8. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-53.

9. Gan WQ, Man SPF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systematic review and a meta-analysis. Thorax 2004; 59: 574-580.

10. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992-997.